COMPANY:

Epredia

"Epredia...today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx). The E1000 Dx consists of a high-speed, automated, whole-slide imaging digital scanner with medical grade viewer and advanced image management and viewer software that creates high-resolution digital images of up to 1,500 tissue samples daily. This can allow laboratories to maximize throughput and streamline cancer diagnostics. With this clearance, Epredia adds clinical use to its portfolio of digital pathology technology, which has the potential to make diagnostics more efficient and accurate."

"Abacus dx is thrilled to announce a new commercial partnership with Epredia for their full core anatomic pathology line of solutions. This collaboration enhances our innovative histology product portfolio, furthering our commitment to providing high-quality IVD solutions across the country...Effective July 1st, 2024, Abacus dx will distribute Epredia’s anatomic pathology solutions to the Clinical market in Australia and New Zealand."